Biopsy Devices Market Forecast to 2027
                     Biopsy Devices Market 
Biopsy Devices Market Forecast to 
2027 - COVID-19 Impact and Global 
Analysis by Product (Needle-Based 
Biopsy, Localization Wires, Procedure 
Trays, and Others); Technology (CT 
Scan, Ultrasound-Guided Biopsy, 
Stereotactic-Guided Biopsy, MRI-
Guided Biopsy, and Others); 
Application (Lung Biopsy, Kidney 
Biopsy, Liver Biopsy, Breast Biopsy, and 
Others); and Geography
Biopsy Devices Market 
Current and future Market Scenario
 According to a new market research study titled ‘Biopsy Devices Market- Global Analysis and Forecasts by Product, 
Technology, Application, and End User, the global biopsy devices market-is expected to reach US$ 3,584.20 Mn in 2027 
from US$ 2,230.86 Mn in 2019. 
 The market is estimated to grow with a CAGR of 6.2% from 2020-2027. The report highlights trends prevailing in the 
global biopsy devices market with the factors driving the market growth and those hampering it. 
The biopsy devices market is segmented on the basis of product into needle-based biopsy, procedure trays, localization 
wires, and others. In 2019, the needle-based biopsy segment accounted for the largest share of the global biopsy devices 
market. 
 This segment is also expected to dominate the market in 2027. The growth of the market for this segment is attributed to 
increasing adoption of needle based-biopsy procedures due to their high accuracy, with minimal injury.  Furthermore, 
the segment is also likely to witness the fastest CAGR in the market during the forecast years.
Key Findings
 According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers, 
have increased by 324% in India from 2017 to 2018. Additionally, the total number of patients visiting Non-
Communicable Diseases (NCD) clinics has doubled between 2017 and 2018, which is recorded to be 35 million and 66 
million, respectively.
 The growth of the market for this segment is attributed to increasing adoption of needle based-biopsy procedures due 
to their high accuracy, with minimal injury. Furthermore, the segment is also likely to witness the fastest CAGR in the 
market during the forecast years.
Market Insights
Increasing Cancer Rates 
Biopsy refers to a diagnostic test that helps identify various types of cancer and non-cancerous abnormalities in the 
human body. The increasing prevalence of cancer among population is likely to augment the growth of the biopsy devices 
market across the world. For instance, in Canada, cancer is the leading cause of death among population, and it is 
witnessed to be a second-leading cause after heart diseases in the US. As per the American Cancer Society, ~1.9 million 
new cancer cases and 693,000 cancer deaths were recorded in 2018. Prostate cancers are the most commonly diagnosed 
cancers among males in North America; however, breast cancers remain leading in females.
Biopsy Devices Market  
Market Segments
 
Technology (CT Scan, Application (Lung Biopsy, 
By Product (Needle-Based Ultrasound-Guided Biopsy, Kidney Biopsy, Liver Biopsy, 
Biopsy, Localization Wires, Stereotactic-Guided Biopsy, Breast Biopsy, and Others); 
Procedure Trays, and Others) MRI-Guided Biopsy, and and Geography
Others)
Biopsy Devices Market  
Dominating Segments
 
 Based on technology, the global biopsy devices market is segmented into CT-scan, ultrasound-guided biopsy, 
  stereotactic biopsy, MRI, and others. In 2019, the ultrasound-guided biopsy segment held the largest share of 
the market.
 The global biopsy devices market, based on application, is segmented into lung biopsy, kidney biopsy, liver 
biopsy, breast biopsy, and others. In 2019, the breast biopsy segment held the largest share of the market, 
and it is also expected to register the highest CAGR during 2020–2027.
 According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast 
cancers, have increased by 324% in India from 2017 to 2018. Additionally, the total number of patients 
visiting Non-Communicable Diseases (NCD) clinics has doubled between 2017 and 2018, which is recorded to 
be 35 million and 66 million, respectively. 
Dominating Segments
Product Insights
Products Insights
 the needle-based biopsy segment accounted for the largest share of the global biopsy devices market. The growth 
of the market for this segment is attributed to increasing adoption of needle based-biopsy procedures due to their 
high accuracy, with minimal injury. 
 A needle biopsy is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle 
biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue 
or fluid samples from muscles, bones, and other organs, such as the liver or lungs.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPHE100001402/?source=other-10389 
Dominating Segments
The report analyzes biopsy devices market on the basis of following segments:
 
By Product
Needle-Based Biopsy
Core Biopsy Devices
Aspiration Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Localization Wires
Procedure Trays
Others
Dominating Segments
By Technology
CT-Scan
Ultrasound-Guided Biopsy
Stereotactic-Guided Biopsy
MRI-Guided Biopsy
Others
By Application
Lung Biopsy
Kidney Biopsy
Liver Biopsy
Breast Biopsy
Others
Biopsy Devices Market 
Leading Players
Company Profiles in Hemophilia Treatment Market are:
BD
B. Braun Melsungen AG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Medical LLC
Danaher
Fujifilm Corporation
Hologic, Inc.
Medtronic
Argon Medical Devices
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
Biopsy Devices Market  
 
 
 Biopsy Devices Market 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/biopsy-devices-market/?source=others-10389 
 
Thank You! 
Thank You!